"A STUDY TO EVALUATE THE USE OF GALA, VASCULAR CONDUIT PRESERVATION SOLUTION IN PATIENTS UNDERGOING CABG. GALA SOLUTION (SOMVC001) FOR THE PRESERVATION, STORAGE AND FLUSHING OF SAPHENOUS VEIN GRAFTS."

Registry ID

003

Source registry

HEALTH_CANADA

Status

Ongoing

Study type

INTERVENTIONAL

Sponsor

SOMAHLUTION, INC

Start date

2014-09-22

Last update

2014-07-29

Conditions

• TRANSPLANTATION

Related clinical trials

• PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, WITH CROSS-OVER, OF POSOLEUCEL (ALVR105) FOR THE TREATMENT OF ADENOVIRUS INFECTION IN PEDIATRIC AND ADULT PARTICIPANTS RECEIVING STANDARD OF CARE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION
• EARLY INITIATION OF ANTIPLATELET THERAPY IN HEART TRANSPLANTATION (AERIAL)
• A RANDOMIZED TRIAL OF LOW VERSUS MODERATE EXPOSURE BUSULFAN FOR INFANTS WITH SEVERE COMBINED IMMUNODEFICIENCY (SCID) RECEIVING TCR¿¿+/CD19+ DEPLETED TRANSPLANTATION: A PHASE II STUDY BY THE PRIMARY IMMUNE DEFICIENCY TREATMENT CONSORTIUM (PIDTC) AND PEDIATRIC TRANSPLANTATION & CELLULAR THERAPY CONSORTIUM (PTCTC) PIDTC ¿CSIDE¿ PROTOCOL (CONDITIONING SCID INFANTS DIAGNOSED EARLY) PTCTC NMD1801
• CALCINEURIN INHIBITORS IN NEUROLOGICALLY DECEASED DONORS TO DECREASE KIDNEY DELAYED GRAFT FUNCTION (CINERGY)-PILOT
• A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)) FOR THE TREATMENT OF ACUTE ANTIBODY-MEDIATED REJECTION (AMR) IN KIDNEY TRANSPLANT PATIENTS
• ALLOGENEIC ISLET CELLS TRANSPLANTED INTO THE OMENTUM

View on source registry